tirzepatide for ckd 𧬠New data from the SUMMIT trial reveals that long-term (Zepbound) may significantly improve kidney function in patients with obesity, chronic kidney disease (CKD), and heart failure with preserved ejection fraction ( Kidney - βThis announcement today
Description
NEJM 2021 Jastreboff AM et al
Best Pract Res Clin Endocrinol Metab
Retesting after three months helps verify you have reached adequate levels
The primary outcome is the change in body weight (%)
Work with a dietitian to help you learn how to eat healthy to ensure you are getting enough protein and the other vital nutrients your body needs to function as it should
